Search research articles
Contact Us
Filters
Showing results (101-110 of 269) with videos related to
Page
of 27
Sort By:
Plos One
|
October 28, 2017
Use of ferrets for electrophysiologic monitoring of ion transport
Niroop Kaza, S Vamsee Raju, Joan M Cadillac, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 9, 2008
A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation
Amit Gaggar, Patricia L Jackson, Brett D Noerager, et al.
American Journal of Respiratory Cell and Molecular Biology
|
January 1, 2010
Activation of the cystic fibrosis transmembrane conductance regulator by the flavonoid quercetin: potential use as a biomarker of ΔF508 cystic fibrosis transmembrane conductance regulator rescue
Louise C Pyle, Jennifer C Fulton, Peter A Sloane, et al.
American Journal of Respiratory Cell and Molecular Biology
|
February 22, 2021
Novel Correctors and Potentiators Enhance Translational Readthrough in CFTR Nonsense Mutations
Venkateshwar Mutyam, Jyoti Sharma, Yao Li, et al.
Annals of the American Thoracic Society
|
October 12, 2019
Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation
J Kirk Harris, Brandie D Wagner, Edith T Zemanick, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 4, 2018
Changes in Lung Clearance Index in Preschool-aged Patients with Cystic Fibrosis Treated with Ivacaftor (GOAL): A Clinical Trial
Felix Ratjen, Michelle Klingel, Philip Black, et al.
Thorax
|
September 11, 2012
Progress in cystic fibrosis and the CF Therapeutics Development Network
Steven M Rowe, Drucy S Borowitz, Jane L Burns, et al.
Heliyon
|
April 29, 2024
Longitudinal improvements in clinical and functional outcomes following initiation of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis
Kadambari Vijaykumar, Hui Min Leung, Amilcar Barrios, et al.
BMC Pulmonary Medicine
|
February 16, 2018
Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients
Bryan A Garcia, Jacque L Carden, Dana L Goodwin, et al.
Scientific Reports
|
July 17, 2024
Reduced sialylation of airway mucin impairs mucus transport by altering the biophysical properties of mucin
Elex S Harris, Hannah J McIntire, Marina Mazur, et al.
Page
of 27
Search research articles
Search
Showing results (101-110 of 269) with videos related to
Sort By:
Page
of 27
Plos One
|
October 28, 2017
Use of ferrets for electrophysiologic monitoring of ion transport
Niroop Kaza, S Vamsee Raju, Joan M Cadillac, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 9, 2008
A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation
Amit Gaggar, Patricia L Jackson, Brett D Noerager, et al.
American Journal of Respiratory Cell and Molecular Biology
|
January 1, 2010
Activation of the cystic fibrosis transmembrane conductance regulator by the flavonoid quercetin: potential use as a biomarker of ΔF508 cystic fibrosis transmembrane conductance regulator rescue
Louise C Pyle, Jennifer C Fulton, Peter A Sloane, et al.
American Journal of Respiratory Cell and Molecular Biology
|
February 22, 2021
Novel Correctors and Potentiators Enhance Translational Readthrough in CFTR Nonsense Mutations
Venkateshwar Mutyam, Jyoti Sharma, Yao Li, et al.
Annals of the American Thoracic Society
|
October 12, 2019
Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation
J Kirk Harris, Brandie D Wagner, Edith T Zemanick, et al.
American Journal of Respiratory and Critical Care Medicine
|
April 4, 2018
Changes in Lung Clearance Index in Preschool-aged Patients with Cystic Fibrosis Treated with Ivacaftor (GOAL): A Clinical Trial
Felix Ratjen, Michelle Klingel, Philip Black, et al.
Thorax
|
September 11, 2012
Progress in cystic fibrosis and the CF Therapeutics Development Network
Steven M Rowe, Drucy S Borowitz, Jane L Burns, et al.
Heliyon
|
April 29, 2024
Longitudinal improvements in clinical and functional outcomes following initiation of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis
Kadambari Vijaykumar, Hui Min Leung, Amilcar Barrios, et al.
BMC Pulmonary Medicine
|
February 16, 2018
Implementation of a successful eradication protocol for Burkholderia Cepacia complex in cystic fibrosis patients
Bryan A Garcia, Jacque L Carden, Dana L Goodwin, et al.
Scientific Reports
|
July 17, 2024
Reduced sialylation of airway mucin impairs mucus transport by altering the biophysical properties of mucin
Elex S Harris, Hannah J McIntire, Marina Mazur, et al.
Page
of 27